Absci Corp reports results for the quarter ended September 30 - Earnings Summary

Absci Corp reports results for the quarter ended September 30 - Earnings Summary
  • Absci Corp ABSI.OQ reported a quarterly adjusted loss of 19 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -20 cents. The mean expectation of ten analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -22 cents to -19 cents per share.

  • Revenue fell 19.6% to $304.00 thousand from a year ago; analysts expected $727.13 thousand.

  • Absci Corp's reported EPS for the quarter was a loss of 19 cents​.

  • The company reported a quarterly loss of $33.3 million.

  • Absci Corp shares had fallen by 6.0% this quarter and gained 190.0% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 0.1% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

  • Wall Street's median 12-month price target for Absci Corp is $15.00, about 32.5% above its last closing price of $10.12

This summary was machine generated from LSEG data November 12 at 03:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

-0.20

-0.19

Beat

Jun. 30 2026

-0.20

-0.21

Missed

Mar. 31 2026

-0.21

-0.19

Beat

Dec. 31 2025

-0.19

-0.20

Missed

Recent news on AbSci

See all news